| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Merrifield C Ann is a Director at Lyra Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $8K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 | LYRA Lyra Therapeutics, Inc. | Director | Buy | 4,000 | $5.05 | $20,200.00 | +54.6% | +24.4% | -42.0% | |
| May 16, 2022 | LYRA Lyra Therapeutics, Inc. | Director | Buy | 3,828 | $4.83 | $18,485.50 | +36.5% | +23.9% | -45.6% | |
| Jun 17, 2021 | LYRA Lyra Therapeutics, Inc. | Director | Buy | 3,500 | $8.97 | $31,394.65 | New | -8.5% | -44.9% |